Affimed Announces Presentations at the AACR Annual Meeting 2021 – GlobeNewswire
stemadminCord Blood Stem CellsNo comments

Heidelberg, Germany, March 10, 2021 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that preclinical anti-tumor efficacy in vivo data from its innate cell engager (ICE) AFM24 have been accepted for e-poster presentation at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, being held on April 10-15. In addition, early data from a Phase 1 study evaluating AFM13 preloaded CAR-like cord blood-derived NK cells followed by weekly AFM13 monotherapy in patients with recurrent or refractory CD30-expressing lymphomas at The University of Texas MD Anderson Cancer Center will be presented by Katy Rezvani during a Major Symposium on April 13th.

Read more
Black people are three times less likely to find a bone marrow donor than white people – WLNS
stemadminCord Blood Stem CellsNo comments

LANSING, Mich. (WLNS) More than three-quarters of African Americans are unable to find a bone marrow or stem cell transplant who need one, according to the nations largest bone marrow registry, Be the Match. There are more than 20 million people on the registry, a database of people who volunteer to donate their stem cells or bone marrow if theyre found to be a match to someone seeking a transplant, and oftentimes, a transplant can mean giving people a second chance at life.

Read more
Therapeutic Solutions International Spin-off Campbell Neurosciences Announces Umbilical Cord Derived Monocyte Immunotherapy Candidate for Suicide…
stemadminCord Blood Stem CellsNo comments

ELK CITY, Idaho, March 4, 2021 /PRNewswire/ --Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today preclinical results and filing of a patent covering the use of manipulated cord blood derived monocytes for prevention of suicidal ideations as well as inflammation of the brain. Company scientists found that administration of non-stem cell components of cord blood to mice exposed to brain inflammation resulted in protection of neurological function as well as suppression of immunological proteins associated in humans with suicidal thoughts.

Read more
Hematopoietic Stem Cell Transplantation (HSCT) Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies…
stemadminCord Blood Stem CellsNo comments

Industry Growth Insights (IGI) has included a latest report on the Global Hematopoietic Stem Cell Transplantation (HSCT) Market into its archive of market research studies. The report is an amalgamation of detailed market overview based on the segmentations, applications, trends and opportunities, mergers and acquisitions, drivers, and restraints. The report showcases the current and forthcoming technical and financial details of the Hematopoietic Stem Cell Transplantation (HSCT) market.

Read more
Global Hematopoietic Stem Cells Transplantation Market 2020 In-depth study, Size, Trends, Emerging Growth Factors and Regional Forecast to 2025 The…
stemadminCord Blood Stem CellsNo comments

The latest published report namelyGlobal Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2020-2025 added byMarketandResearch.bizoffers an insightful take on the historical data of the market and predictions for 2020 to 2025 time-period. The report provides an understanding of the global Hematopoietic Stem Cells Transplantation industry competitors, the sales channel, growth potential, potentially disruptive trends, industry product innovations and the value/volume of size, market segments, and market share of the best actors/products

Read more

Theme: Illdy.